135.39
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Ligand Pharmaceuticals Inc Aktie (LGND) Neueste Nachrichten
Price Channel Expanding on Ligand Pharmaceuticals Incorporated’s ChartReal Time Trade Opportunity Alerts Monitor Market Surges - metal.it
What is the risk reward ratio of investing in Ligand Pharmaceuticals Incorporated stockHigh-yield investments - Jammu Links News
How does Ligand Pharmaceuticals Incorporated compare to its industry peersDiscover undervalued opportunities early - Jammu Links News
Why is Ligand Pharmaceuticals Incorporated stock attracting strong analyst attentionAchieve rapid financial growth with smart picks - Jammu Links News
What makes Ligand Pharmaceuticals Incorporated stock price move sharplyFastest return on investment - Jammu Links News
Is Ligand Pharmaceuticals Incorporated a good long term investmentCapitalize on momentum-driven opportunities - Jammu Links News
Ligand Pharmaceuticals to meet with Oppenheimer on July 28-29 - AInvest
Ligand Pharmaceuticals Incorporated to Host Earnings Call - ACCESS Newswire
Orchestra BioMed secures $70 million from Ligand and Medtronic - Investing.com
Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed - GlobeNewswire
$70M Strategic Investment Powers Orchestra BioMed's Revolutionary Leadless Pacemaker Technology - Stock Titan
How Ligand Pharmaceuticals Incorporated stock performs during market volatilityTrend Analysis for Safer Trades Gains Popularity - beatles.ru
When is Ligand Pharmaceuticals Incorporated stock expected to show significant growthSmart Portfolio Planner With Proven Results - Jammu Links News
Ligand Pharmaceuticals Price Target Raised Amid Positive Developments - AInvest
Oppenheimer Raises Ligand Pharmaceuticals PT to $162 from $145 to Outperform. - AInvest
Oppenheimer raises Ligand Pharma stock price target to $162 on royalty growth - Investing.com Australia
Oppenheimer raises Ligand Pharma stock price target to $162 on royalty growth By Investing.com - Investing.com South Africa
Key External Factors That Drive Ligand Pharmaceuticals Incorporated Stock Price MovementsLow Risk Equity Screener With Results Shared - metal.it
Ligand Pharmaceuticals Incorporated Recovery Likely Here’s What Data ShowsAI Powered High Return Stock Calls Dominate Watchlists - metal.it
Published on: 2025-07-29 17:16:20 - metal.it
EQUITY NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Ligand Pharmaceuticals Incorporated and Encourages Investors with Losses to Contact the Firm - ACCESS Newswire
Why Ligand Pharmaceuticals Incorporated stock attracts strong analyst attentionDaily Stock Market Swing Alerts Highlight Key Movers - metal.it
Published on: 2025-07-29 03:23:14 - metal.it
What are Ligand Pharmaceuticals Incorporated company’s key revenue driversUnprecedented profits - jammulinksnews.com
RSI Crosses Above 30 for Ligand Pharmaceuticals Incorporated — Reversal in SightAI Based High Gain Watchlist Scanner Shared - beatles.ru
Is Ligand Pharmaceuticals Incorporated stock overvalued or undervaluedHigh-performance investment picks - Jammu Links News
Is Ligand Pharmaceuticals Incorporated stock a growth or value playPrecision Entry Strategy - metal.it
Ligand Pharmaceuticals Incorporated Company Revenue and Profit Trends: A Deep Dive10x Potential Stocks - metal.it
New Product Launches: Will They Boost Ligand Pharmaceuticals Incorporated Stock in 2025Daily Stock Radar - metal.it
Ligand Pharmaceuticals Incorporated Stock Analysis and ForecastHigh-margin investment plays - PrintWeekIndia
What analysts say about Ligand Pharmaceuticals Incorporated stockFree Capital Growth Strategies - PrintWeekIndia
What drives Ligand Pharmaceuticals Incorporated stock priceBreakout portfolio performance - Autocar Professional
Ligand to Report Second Quarter 2025 Financial Results on August 7, 2025 - Yahoo Finance
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):